Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
153.70
-1.84 (-1.19%)
At close: May 13, 2026, 4:00 PM EDT
153.52
-0.17 (-0.11%)
After-hours: May 13, 2026, 4:10 PM EDT

Belite Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
352.9331.6888.1642.0917.34
Short-Term Investments
139.49113.47---
Cash & Short-Term Investments
492.42145.1588.1642.0917.34
Cash Growth
239.25%64.65%109.45%142.67%-32.30%
Other Receivables
0.70.580.840-
Total Trade Receivables
0.70.580.840-
Other Current Assets
1.151.350.950.720.09
Total Current Assets
494.27147.0789.9442.8117.43
Net Property, Plant & Equipment
0.780.971.31.350.09
Other Intangible Assets
0.020.03---
Long-Term Investments
566.455.06---
Other Long-Term Assets
5.324.063.40.120.82
Total Assets
780.56152.1394.6444.2718.35
Accrued Expenses
9.645.763.331.911.56
Current Portion of Leases
0.240.280.310.2-
Other Current Liabilities
0.010.01--0.07
Total Current Liabilities
9.886.053.632.11.64
Long-Term Leases
0.190.260.580.67-
Total Long-Term Liabilities
0.190.260.580.67-
Total Liabilities
10.076.314.212.771.64
Common Stock
00000
Additional Paid-in Capital
956.28254.13162.3181.7612.33
Accumulated Other Comprehensive Income
-0.54-0.66-0.37-0.39-0.2
Retained Earnings
-185.26-107.65-71.5-39.87-27.22
Total Common Shareholders' Equity
770.49145.8290.4341.5-15.09
Minority Interest
----31.81
Shareholders' Equity
770.49145.8290.4341.516.71
Total Liabilities & Equity
780.56152.1394.6444.2718.35
Total Debt
0.430.540.890.870
Net Cash (Debt)
491.99144.6187.2741.2217.34
Net Cash Growth
240.22%65.70%111.71%137.68%-32.30%
Net Cash Per Share
14.674.743.282.061.81
Book Value
770.49145.8290.4341.5-15.09
Book Value Per Share
22.974.783.402.08-1.58
Tangible Book Value
770.47145.7990.4341.5-15.09
Tangible Book Value Per Share
22.974.773.402.08-1.58
Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q